Cholestatic hepatitis associated with repaglinide

Diabetes Care. 2005 Mar;28(3):752-3. doi: 10.2337/diacare.28.3.752-a.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Carbamates / adverse effects*
  • Chemical and Drug Induced Liver Injury / etiology
  • Cholestasis / chemically induced*
  • Diabetes Mellitus, Type 2 / drug therapy
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Male
  • Piperidines / adverse effects*

Substances

  • Carbamates
  • Hypoglycemic Agents
  • Piperidines
  • repaglinide